Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJohnson Matthey Regulatory News (JMAT)

Share Price Information for Johnson Matthey (JMAT)

Share Price is delayed by 15 minutes
Get Live Data
2,080.00    -62.00 (-2.89%)
Bid:
2,066.00
Ask:
2,070.00
Spread: 4.00 (0.194%)
Market Cap: £3.48b
JMAT Live PriceLast checked at - London Stock Exchange

Intraday Johnson Matthey Share Chart

Share buyback programme

14 Feb 2022 07:00

RNS Number : 5097B
Johnson Matthey PLC
14 February 2022
 

14th February 2022

 

Johnson Matthey Plc

Share buyback programme

 

On 24th November 2021, Johnson Matthey Plc ("JM" or the "Company") announced its intention to conduct a share buyback programme of its ordinary shares up to a maximum consideration of £200m.

 

The first tranche of the share buyback programme of up to £100m commenced on 21st December 2021 and completed on 28th January 2022, in accordance with its terms.

 

The Company announces that the second tranche of the share buyback programme of up to £100m (the "Programme") will commence today and will end no later than 20th May 2022.

The Company has entered into an irrevocable, non-discretionary agreement with Citigroup Global Markets Ltd ("Citi") to manage the Programme, pursuant to which Citi will purchase Johnson Matthey ordinary shares (acting as principal) for subsequent repurchase by the Company. Citi will make trading decisions under the Programme independently of JM. Purchases may continue during any closed period to which the Company is subject.

 

The sole purpose of the Programme is to reduce the share capital of the Company. All shares repurchased under the Programme will be cancelled.

 

The maximum number of shares that may be repurchased under the Programme is 19,353,343 shares, being the number of shares the Company is authorised to purchase pursuant to the authority granted by shareholders at the Company's 2021 Annual General Meeting (the "2021 AGM"), less the number of shares that have already been repurchased pursuant to that authority.

Any purchase of the Company's ordinary shares in relation to this announcement will be effected within certain pre-set parameters and in accordance with JM's general authority to repurchase ordinary shares granted by its shareholders at the 2021 AGM, the Market Abuse Regulation 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018), and Chapter 12 of the Financial Conduct Authority's Listing Rules. No repurchases will be made in respect of the Company's American Depositary Receipts.

 

ENDS

 

Enquiries: 

 

 

 

Martin Dunwoodie

Victoria Barlow

 

Director of Investor Relations

Deputy Company Secretary

 

+44 20 7269 8241

+44 20 7269 8431

 

 

 

 

 

 

 

 

 

 

Johnson Matthey Plc is listed on the London Stock Exchange (JMAT)

Registered in England & Wales number: 00033774Legal Entity Identifier number: 2138001AVBSD1HSC6Z10 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSBKNBDKBKBNBD
Date   Source Headline
18th Jan 20242:30 pmRNSHolding(s) in Company
18th Jan 202411:54 amRNSDirector/PDMR Shareholding
10th Jan 20241:29 pmRNSHolding(s) in Company
9th Jan 20241:31 pmRNSHolding(s) in Company
5th Jan 20244:50 pmRNSHolding(s) in Company
4th Jan 20244:26 pmRNSHolding(s) in Company
2nd Jan 20243:27 pmRNSHolding(s) in Company
28th Dec 20231:35 pmRNSHolding(s) in Company
21st Dec 20231:25 pmRNSDirector/PDMR Shareholding
19th Dec 20232:29 pmRNSHolding(s) in Company
15th Dec 20239:00 amRNSHolding(s) in Company
13th Dec 20233:01 pmRNSHolding(s) in Company
11th Dec 20234:20 pmRNSHolding(s) in Company
7th Dec 20231:41 pmRNSHolding(s) in Company
6th Dec 20231:52 pmRNSHolding(s) in Company
6th Dec 202312:00 pmRNSDirector/PDMR Shareholding
5th Dec 20232:56 pmRNSHolding(s) in Company
1st Dec 20233:56 pmRNSHolding(s) in Company
1st Dec 20233:54 pmRNSHolding(s) in Company
28th Nov 20239:00 amRNSDirector/PDMR Shareholding
22nd Nov 20237:00 amRNSBoard Committee changes
22nd Nov 20237:00 amRNSJohnson Matthey half year results
16th Nov 20234:23 pmRNSDirector/PDMR Shareholding
14th Nov 20233:16 pmRNSHolding(s) in Company
13th Nov 20234:33 pmRNSHolding(s) in Company
10th Nov 20238:00 amRNSHolding(s) in Company
25th Oct 20232:31 pmRNSHolding(s) in Company
24th Oct 20233:35 pmRNSHolding(s) in Company
23rd Oct 20234:30 pmRNSHolding(s) in Company
19th Oct 202312:26 pmRNSDirector/PDMR Shareholding
18th Oct 20239:00 amRNSHolding(s) in Company
16th Oct 20234:10 pmRNSHolding(s) in Company
10th Oct 20235:58 pmRNSHolding(s) in Company
10th Oct 20237:00 amRNSHolding(s) in Company
5th Oct 20232:30 pmRNSHolding(s) in Company
4th Oct 20232:21 pmRNSHolding(s) in Company
3rd Oct 20233:45 pmRNSHolding(s) in Company
3rd Oct 20238:00 amRNSHolding(s) in Company
2nd Oct 20237:00 amRNSCompletion of Diagnostic Services sale
29th Sep 20238:00 amRNSHolding(s) in Company
22nd Sep 20234:09 pmRNSHolding(s) in Company
22nd Sep 20231:59 pmRNSDirector/PDMR Shareholding
21st Sep 20234:22 pmRNSHolding(s) in Company
20th Sep 20233:31 pmRNSHolding(s) in Company
20th Sep 20237:00 amRNSHolding(s) in Company
15th Sep 20235:43 pmRNSHolding(s) in Company
13th Sep 20231:50 pmRNSHolding(s) in Company
13th Sep 20237:00 amRNSHolding(s) in Company
8th Sep 20238:00 amRNSHolding(s) in Company
5th Sep 20238:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.